Financhill
Buy
68

GRAF Quote, Financials, Valuation and Earnings

Last price:
$10.72
Seasonality move :
2.22%
Day range:
$10.66 - $10.74
52-week range:
$10.07 - $11.77
Dividend yield:
0%
P/E ratio:
35.59x
P/S ratio:
--
P/B ratio:
1.32x
Volume:
1.7K
Avg. volume:
33.2K
1-year change:
6.55%
Market cap:
$308.5M
Revenue:
--
EPS (TTM):
$0.30
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $133.8K $3.2K $531.3K
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- $133.8K $3.2K $531.3K
Operating Income -- -- -$133.8K -$3.2K -$531.3K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$133.8K -$3.2K $5.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -$133.8K -$3.2K $5.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$133.8K -$3.2K $5.2M
 
Basic EPS (Cont. Ops) -- -- -$0.01 -$0.00 $0.18
Diluted EPS (Cont. Ops) -- -- -$0.01 -$0.00 $0.18
Weighted Average Basic Share -- -- $25M $28.8M $28.8M
Weighted Average Diluted Share -- -- $25M $28.8M $28.8M
 
EBITDA -- -- -$133.8K -$3.2K -$531.3K
EBIT -- -- -$133.8K -$3.2K -$531.3K
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -$133.8K -$3.2K -$531.3K
Operating Income (Adjusted) -- -- -$133.8K -$3.2K -$531.3K
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $195.2K $798.2K
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $195.2K $798.2K
Operating Income -- -- -- -$195.2K -$798.2K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- $2.8M $1.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- $2.8M $1.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $2.8M $1.7M
 
Basic EPS (Cont. Ops) -- -- -- $0.10 $0.06
Diluted EPS (Cont. Ops) -- -- -- $0.10 $0.06
Weighted Average Basic Share -- -- $28.8M $28.8M $28.8M
Weighted Average Diluted Share -- -- $28.8M $28.8M $28.8M
 
EBITDA -- -- -- -$195.2K -$798.2K
EBIT -- -- -- -$195.2K -$798.2K
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$195.2K -$798.2K
Operating Income (Adjusted) -- -- -- -$195.2K -$798.2K
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $312.5K $1.5M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $312.5K $1.5M
Operating Income -- -- -- -$312.5K -$1.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- $2.8M $8.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- $2.8M $8.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $2.8M $8.7M
 
Basic EPS (Cont. Ops) -- -- -- $0.10 $0.30
Diluted EPS (Cont. Ops) -- -- -- $0.10 $0.30
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -$312.6K -$1.5M
EBIT -- -- -- -$312.6K -$1.5M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$312.5K -$1.5M
Operating Income (Adjusted) -- -- -- -$312.6K -$1.5M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $312.5K $1.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $312.5K $1.3M
Operating Income -- -- -- -$312.5K -$1.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- $2.8M $6.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- $2.8M $6.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $2.8M $6.2M
 
Basic EPS (Cont. Ops) -- -- -- $0.10 $0.22
Diluted EPS (Cont. Ops) -- -- -- $0.10 $0.22
Weighted Average Basic Share -- -- $63.3M $86.3M $86.3M
Weighted Average Diluted Share -- -- $63.3M $86.3M $86.3M
 
EBITDA -- -- -- -$312.5K -$1.3M
EBIT -- -- -- -$312.5K -$1.3M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$312.5K -$1.3M
Operating Income (Adjusted) -- -- -- -$312.5K -$1.3M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents -- -- -- -- $479.6K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $237.5K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- -- $717.1K
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- $235.8M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- $235.8M
Total Assets -- -- -- -- $236.6M
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- $150.1K $150.4K $169.7K
Current Portion Of Long-Term Debt -- -- $2.8K $5.7K --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- $152.9K $156.1K $169.7K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $152.9K $156.1K $10M
 
Common Stock -- -- $600 $600 $235.8M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -$153K -$156.1K $226.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -$152.9K -$156.1K $226.6M
 
Total Liabilities and Equity -- -- -- -- $236.6M
Cash and Short Terms -- -- -- -- $479.6K
Total Debt -- -- -- -- --
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents -- -- -- $568.8K $700
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $261.7K $195.7K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $830.5K $196.4K
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- $243.2M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- $233.1M --
Total Assets -- -- -- $234.1M $243.4M
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- $120.8K --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $120.8K $804K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $9.9M $10.6M
 
Common Stock -- -- -- $233.1M $243.2M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $224.2M $232.8M
 
Total Liabilities and Equity -- -- -- $234.1M $243.4M
Cash and Short Terms -- -- -- $568.8K $700
Total Debt -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -- -$133.8K -$3.2K $5.2M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$912K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$230M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$155.7K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$452.7K
Cash From Financing -- -- -- -- $231.4M
 
Beginning Cash (CF) -- -- -- -- $479.6K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $479.6K
Ending Cash (CF) -- -- -- -- $959.3K
 
Levered Free Cash Flow -- -- -- -- -$912K
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -- -- -- $2.8M $1.7M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$585.7K -$106.5K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$5.7K --
Cash From Financing -- -- -- -$5.7K --
 
Beginning Cash (CF) -- -- -- $568.8K $700
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$591.4K -$106.5K
Ending Cash (CF) -- -- -- -$22.6K -$105.8K
 
Levered Free Cash Flow -- -- -- -$585.7K -$106.5K
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -- -- -- $2.8M $8.7M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$827.5K -$478.5K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- -$89.6K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- -$568.1K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -$827.5K -$478.4K
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -- -- -- $2.8M $6.2M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- -$100
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$827.4K -$393.9K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$230M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$155.7K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$448.1K --
Cash From Financing -- -- -- $231.4M -$85K
 
Beginning Cash (CF) -- -- -- $1.7M $468.1K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $568.8K -$478.9K
Ending Cash (CF) -- -- -- $2.3M -$10.8K
 
Levered Free Cash Flow -- -- -- -$827.4K -$393.9K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock